Abstract
This report analyzes the worldwide markets for Anti-Obesity Drugs in Millions
of US$. The report provides separate comprehensive analytics for the US,
Europe, and Rest of World. Annual forecasts are provided for each region for
the period of 2005 through 2015. The report profiles 85 companies including
many key and niche players worldwide such as Abbott Laboratories, Alizyme Plc,
Amylin Pharmaceuticals, Inc., AstraZeneca Plc., F.HOFFMANN-LA ROCHE LTD.,
GlaxoSmithKline Plc, Sanofi-Aventis SA, SuperGen, Inc., Takeda Pharmaceutical
Company Limited, and VIVUS, Inc. Market data and analytics are derived from
primary and secondary research. Company profiles are mostly extracted from URL
research and reported select online sources.
| 
View Cart
